Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans

Obesity Research

Volumn 11, Issue 3, 2003, Pages 368-376

  Staiger, Harald ^a   Tschritter, Otto ^a   Machann, Jürgen ^b   Thamer, Claus ^a   Fritsche, Andreas ^a   Maerker, Elke ^a   Schick, Fritz ^b   Häring, Hans Ulrich ^a   Stumvoll, Michael ^a,c  

^a Medical Clinic   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c Klinikum der Universität   (Germany)

Author keywords

Adipocytokines; Fat depot specificity; Subcutaneous fat; Visceral fat; Waist to hip ratio

Indexed keywords

ADIPONECTIN; LEPTIN; PROTEIN; SIGNAL PEPTIDE;

ADIPOSE TISSUE; ADULT; ARTICLE; BLOOD; BODY COMPOSITION; BODY CONSTITUTION; DIET RESTRICTION; FEMALE; HUMAN; MALE; STATISTICAL MODEL; VISCERA;

ADIPONECTIN; ADIPOSE TISSUE; ADULT; BODY COMPOSITION; BODY CONSTITUTION; FASTING; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; LINEAR MODELS; MALE; PROTEINS; VISCERA;

EID: 0038207759     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2003.48     Document Type: Article

References (20)

1. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med. 1998; 15:539-53.
2. Kissebah AH, Vydelingum N, Murray R, et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab. 1982;54:254-60.
3. Wahrenberg H, Lönnqvist F, Arner P. Mechanisms underlying regional differences in lipolysis in human adipose tissue. J Clin Invest. 1989;84:458-62.
4. Bolinder J, Kager L, Östman J. Differences at the receptor and post-receptor levels between human omental and subcutaneous adipose tissue in the action of insulin in lipolysis. Diabetes. 1983;32:117-23.
5. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive leptin concentrations in normal weight and obese humans. N Engl J Med. 1996;334:292-5.
6. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86:1930-5.
7. Oral EA, Simha V, Ruiz E, et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med. 2002;346:570-8.
8. Petersen KF, Oral EA, Dufour S, et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest. 2002;109:1345-50.
9. Stefan N, Vozarova B, Funahashi T, et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes. 2002;51:1884-8.
10. Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest. 2001;108:1875-81.
11. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7:941-6.
12. 1H-MRS. J Magn Reson Imaging. 2000;12:306-10.
13. Halleux CM, Takahashi M, Delporte ML, et al. Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochem Biophys Res Commun. 2001;288:1102-7.
14. Berg AH, Combs TP, Scherer PE. Acrp30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab. 2002;13:84-9.
15. Minocci A, Savia G, Lucantoni R, et al. Leptin plasma concentrations are dependent on body fat distribution in obese patients. Int J Obes Relat Metab Disord. 2000;24:1139-44.
16. Van Harmelen V, Reynisdottir S, Eriksson P, et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes. 1998;47:913-7.
17. Montague CT, Prins JB, Sanders L, Digby JE, O'Rahilly S. Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes. 1997;46:342-7.
18. Hube F, Lietz U, Igel M, et al. Difference in leptin mRNA levels between omental and subcutaneous abdominal adipose tissue from obese humans. Horm Metab Res. 1996;28:690-3.
19. Tai ES, Lau TN, Ho SC, Fok AC, Tan CE. Body fat distribution and cardiovascular risk in normal weight women. Associations with insulin resistance, lipids and plasma leptin. Int J Obes Relat Metab Disord. 2000;24:751-7.
20. Statnick MA, Beavers LS, Conner LJ, et al. Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes. Int J Exp Diabetes Res. 2000;1:81-8.